What's new

Opinion/decision on a Paediatric investigation plan (PIP): Aspaveli, Pegcetacoplan, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Renal and urinary disorders, PIP number: P/0030/2024

Opinion/decision on a Paediatric investigation plan (PIP): Aspaveli, Pegcetacoplan, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Renal and urinary disorders, PIP number: P/0030/2024

Mar 17, 2025 - 12:06
 0
Opinion/decision on a Paediatric investigation plan (PIP): Aspaveli, Pegcetacoplan, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Renal and urinary disorders, PIP number: P/0030/2024
Opinion/decision on a Paediatric investigation plan (PIP): Aspaveli, Pegcetacoplan, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Renal and urinary disorders, PIP number: P/0030/2024
Read More

Tags:

Previous Article

STAT+: Purified T cell transplant lowers risk of immune reaction for blood cance...

Next Article

Reliable industrial policies required to support the ramp-up of European battery...

Related Posts

European medicines agencies network strategy (EMANS) to 2028 webinar, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 13 February 2025, 13:00 (CET) to 13 February 2025, 17:00 (CET)

European medicines agencies network strategy (EMANS) to...

Feb 18, 2025  0

Human medicines European public assessment report (EPAR): Neupro, rotigotine, Date of authorisation: 15/02/2006, Revision: 35, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0

EMEA-003500-PIP01-23

EMEA-003500-PIP01-23

Feb 19, 2025  0